Free cancer treatment? Russia's mRNA vaccine sparks hope for a breakthrough cure

Full Article
Free cancer treatment? Russia's mRNA vaccine sparks hope for a breakthrough cure

Russia has announced a revolutionary mRNA-based cancer vaccine that aims to treat existing tumors rather than prevent cancer. This personalized vaccine utilizes genetic material from a patient's tumor and is expected to be available to the public by early 2025. The Russian government will cover the production cost of approximately 300,000 rubles per dose, but distribution details remain unclear.

The vaccine's development involved collaboration among several research centers, showing promising results in pre-clinical trials for tumor suppression. The integration of artificial intelligence is set to expedite the creation of personalized vaccines, reducing development time significantly. President Vladimir Putin has expressed optimism about Russia's advancements in cancer treatment, highlighting the potential impact of this innovative vaccine.

• AI accelerates the development of personalized cancer vaccines significantly.

• The vaccine targets existing tumors using genetic material from patients.

Key AI Terms Mentioned in this Article

mRNA Vaccine

mRNA vaccines introduce messenger RNA to instruct cells to produce proteins that trigger an immune response.

Artificial Intelligence (AI)

AI is utilized to enhance the speed and efficiency of creating personalized vaccines.

Neural Networks

Neural networks are employed in AI computations to reduce vaccine development time from hours to under an hour.

Companies Mentioned in this Article

Gamaleya National Research Center

This center is involved in the development of the mRNA vaccine, focusing on its efficacy in treating cancer.

Ivannikov Institute

The Ivannikov Institute contributes to the vaccine's design by integrating AI technologies for computational efficiency.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics